Avoiding diabetic ketoacidosis in perioperative and procedure settings: Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are a relatively new class of oral medications for the treatment of type 2 diabetes. While they are particularly helpful for managing blood glucose in diabetic patients with cardiovascular comorbidities, they also come with side-effects and potentially life-threatening risks. This article describes how to safely manage these patients when fasting in perioperative and procedure settings

INTRODUCTION Almost one million Australian adults self-reported a diagnosis of type 2 diabetes in 2017-2018 (4.9% of the total population) (ABS 2019). In addition, an estimated 500,000 people are living [...]